Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy.

[1]  G. Carman,et al.  Phosphatidic Acid Phosphatase, a Key Enzyme in the Regulation of Lipid Synthesis* , 2009, Journal of Biological Chemistry.

[2]  D. Bredt,et al.  AGPAT6 Is a Novel Microsomal Glycerol-3-phosphate Acyltransferase* , 2008, Journal of Biological Chemistry.

[3]  G. Barsh,et al.  Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. , 2008, Cell metabolism.

[4]  A. Garg,et al.  Functional characterization of human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 9: cloning, tissue distribution, gene structure, and enzymatic activity. , 2007, The Journal of endocrinology.

[5]  Shuli Wang,et al.  Hepatic Overexpression of Glycerol-sn-3-phosphate Acyltransferase 1 in Rats Causes Insulin Resistance* , 2007, Journal of Biological Chemistry.

[6]  M. Birnbaum,et al.  Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.

[7]  C. Vinson,et al.  Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality. , 2007, The Journal of clinical investigation.

[8]  K. Reue,et al.  Three Mammalian Lipins Act as Phosphatidate Phosphatases with Distinct Tissue Expression Patterns* , 2006, Journal of Biological Chemistry.

[9]  Dongmei Li,et al.  Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis , 2006, Proceedings of the National Academy of Sciences.

[10]  G. Carman,et al.  Roles of phosphatidate phosphatase enzymes in lipid metabolism. , 2006, Trends in biochemical sciences.

[11]  Long Yu,et al.  Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway. , 2006, Journal of biochemistry and molecular biology.

[12]  A. Garg,et al.  Genetic disorders of adipose tissue development, differentiation, and death. , 2006, Annual review of genomics and human genetics.

[13]  J. Markham,et al.  Separation and Identification of Major Plant Sphingolipid Classes from Leaves* , 2006, Journal of Biological Chemistry.

[14]  J. Repa,et al.  Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. , 2006, Cell metabolism.

[15]  A. Garg,et al.  Functional characterization of human 1-acylglycerol-3-phosphate acyltransferase isoform 8: cloning, tissue distribution, gene structure, and enzymatic activity. , 2006, Archives of biochemistry and biophysics.

[16]  Xianlin Han,et al.  A Regulatory Role for 1-Acylglycerol-3-phosphate-O-acyltransferase 2 in Adipocyte Differentiation* , 2006, Journal of Biological Chemistry.

[17]  R. Coleman,et al.  Agpat6—a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium Published, JLR Papers in Press, January 31, 2006. , 2006, Journal of Lipid Research.

[18]  S. Young,et al.  Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesitys⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional table and figure. Published, JLR Papers in Press, January 25, 2006. , 2006, Journal of Lipid Research.

[19]  A. Morris,et al.  Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. , 2005, The Biochemical journal.

[20]  A. K. Agarwal,et al.  Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy. , 2005, Biochemical and biophysical research communications.

[21]  Dingding Han,et al.  Cloning and characterization a novel human 1-acyl-sn-glycerol-3-phosphate acyltransferase gene AGPAT7 , 2005, DNA sequence : the journal of DNA sequencing and mapping.

[22]  D. Brindley.  Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer , 2004, Journal of cellular biochemistry.

[23]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[24]  J. Brozinick,et al.  A Predominant Role of Acyl-CoA:monoacylglycerol Acyltransferase-2 in Dietary Fat Absorption Implicated by Tissue Distribution, Subcellular Localization, and Up-regulation by High Fat Diet* , 2004, Journal of Biological Chemistry.

[25]  R. Hammer,et al.  Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. , 2004, The Journal of clinical investigation.

[26]  E. Simpson,et al.  Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. , 2004, Endocrinology.

[27]  Robert V Farese,et al.  Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice* , 2004, Journal of Biological Chemistry.

[28]  A. Garg.  Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.

[29]  R. Unger.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.

[30]  S. O’Rahilly,et al.  Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. , 2003, The Journal of clinical endocrinology and metabolism.

[31]  Long Yu,et al.  Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family , 2003, Journal of Human Genetics.

[32]  A. Garg,et al.  Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways , 2003, Trends in Endocrinology & Metabolism.

[33]  Robert V Farese,et al.  MGAT2, a Monoacylglycerol Acyltransferase Expressed in the Small Intestine* , 2003, The Journal of Biological Chemistry.

[34]  J. Lockwood,et al.  Cloning and Functional Characterization of a Mouse Intestinal Acyl-CoA:Monoacylglycerol Acyltransferase, MGAT2* , 2003, The Journal of Biological Chemistry.

[35]  L. E. Hammond,et al.  Mitochondrial Glycerol-3-Phosphate Acyltransferase-Deficient Mice Have Reduced Weight and Liver Triacylglycerol Content and Altered Glycerolipid Fatty Acid Composition , 2002, Molecular and Cellular Biology.

[36]  S. O’Rahilly,et al.  Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy , 2002, Journal of medical genetics.

[37]  Y. Murata,et al.  Effect of estrogen deficiency in the male: the ArKO mouse model , 2002, Molecular and Cellular Endocrinology.

[38]  Robert V Farese,et al.  DGAT1 Is Not Essential for Intestinal Triacylglycerol Absorption or Chylomicron Synthesis* , 2002, The Journal of Biological Chemistry.

[39]  Robert V Farese,et al.  Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Peter Tontonoz,et al.  Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors* , 2002, The Journal of Biological Chemistry.

[41]  R. Hammer,et al.  Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1c* , 2002, The Journal of Biological Chemistry.

[42]  J. Horton.  Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. , 2001, Biochemical Society transactions.

[43]  A. Bowcock,et al.  AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34 , 2002, Nature Genetics.

[44]  R. Hammer,et al.  Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Leung.  The structure and functions of human lysophosphatidic acid acyltransferases. , 2001, Frontiers in bioscience : a journal and virtual library.

[46]  R. Hammer,et al.  SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. , 2001, Genes & development.

[47]  A. Thorburn,et al.  Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Hammer,et al.  Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. , 2000, Molecular cell.

[49]  Robert V Farese,et al.  Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat , 2000, Nature Genetics.

[50]  Jay D. Horton,et al.  Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus* , 1999, The Journal of Biological Chemistry.

[51]  M. Brown,et al.  Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. , 1999, The Journal of clinical investigation.

[52]  M. Olive,et al.  Life without white fat: a transgenic mouse. , 1998, Genes & development.

[53]  R. Hammer,et al.  Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. , 1998, Genes & development.

[54]  D. Brindley,et al.  Mammalian Lipid Phosphate Phosphohydrolases* , 1998, The Journal of Biological Chemistry.

[55]  R. Hammer,et al.  Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. , 1997, The Journal of clinical investigation.

[56]  A. Kumar,et al.  Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells. , 1997, DNA and cell biology.

[57]  R. Hammer,et al.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.

[58]  O. Trygstad,et al.  Generalized lipodystrophy, congenital and acquired (lipoatrophy) , 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[59]  M. Chandalia,et al.  Postmortem findings in congenital generalized lipodystrophy. , 1995, The Journal of clinical endocrinology and metabolism.

[60]  R. Hammer,et al.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.

[61]  J. Roth,et al.  Specificity spillover at the hormone receptor--exploring its role in human disease. , 1989, The New England journal of medicine.

[62]  J. McGarry,et al.  Characteristics of fatty acid oxidation in rat liver homogenates and the inhibitory effect of malonyl-CoA. , 1978, Biochimica et biophysica acta.